TrialAmerican journal of clinical dermatology2025

The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults.

Richard G Langley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.